932730-51-3 Usage
General Description
CDDO-EA, also known as bardoxolone methyl, is a synthetic triterpenoid compound with potential anti-inflammatory, antioxidant, and antineoplastic activities. It functions by activating and inducing the expression of various cytoprotective and detoxifying genes, as well as inhibiting pro-inflammatory signaling pathways. CDDO-EA has been shown to have promising potential in the treatment of various conditions, including chronic kidney disease, cancer, and inflammatory disorders. It is currently being evaluated in clinical trials for its therapeutic effects and safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 932730-51-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,2,7,3 and 0 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 932730-51:
(8*9)+(7*3)+(6*2)+(5*7)+(4*3)+(3*0)+(2*5)+(1*1)=163
163 % 10 = 3
So 932730-51-3 is a valid CAS Registry Number.
932730-51-3Relevant articles and documents
Triterpenoid derivatives and application thereof as programmed cell death inhibitor
-
, (2020/10/29)
The invention discloses a triterpenoid derivative, or a prodrug of an isomer, salt or solvate of the triterpenoid derivative. The triterpenoid derivative has a general formula structure shown in a formula I, wherein substituent groups in the formula are shown in the specification in detail. The triterpenoid derivative or the isomer, salt or solvate prodrug thereof can be used as a programmed celldeath inhibitor to effectively inhibit programmed death of cells and can be used to prepare medicines for preventing and treating ischemic diseases related to programmed cell death.
